A case of pediatric acute myeloid leukemia with t(11;16)(q23;q24) leading to a novel KMT2A-USP10 fusion gene

Genes Chromosomes Cancer. 2018 Oct;57(10):522-524. doi: 10.1002/gcc.22646. Epub 2018 Aug 14.

Abstract

We present a leukemia case that exhibits a chromosomal translocation t(11;16)(q23;q23), which results in the expression of a novel KMT2A fusion gene. This novel fusion, KMT2A-USP10, was found in a relapse of acute myeloid leukaemia M5a. USP10 belongs to a protein family that deubiquitinates a distinct set of target proteins, and thus, increases the steady state protein levels of its target subproteome. One of the USP10 targets is TP53. Wildtype TP53 is usually rescued from proteasomal degradation by USP10. As most KMT2A leukemias display wildtype p53 alleles, one might argue that the disruption of an USP10 allele can be classified as a pro-oncogenic event.

Keywords: FISH; LDI-PCR; MLL/KMT2A; acute myeloblastic leukaemia; cytogenetics.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Chromosomes, Human, Pair 11 / genetics
  • Chromosomes, Human, Pair 16 / genetics
  • Histone-Lysine N-Methyltransferase / genetics*
  • Humans
  • Karyotyping
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myeloid, Acute / pathology
  • Male
  • Myeloid-Lymphoid Leukemia Protein / genetics*
  • Oncogene Proteins, Fusion / genetics
  • Translocation, Genetic / genetics*
  • Tumor Suppressor Protein p53 / genetics
  • Ubiquitin Thiolesterase / genetics*

Substances

  • KMT2A protein, human
  • Oncogene Proteins, Fusion
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • USP10 protein, human
  • Myeloid-Lymphoid Leukemia Protein
  • Histone-Lysine N-Methyltransferase
  • Ubiquitin Thiolesterase